Annals On Call - Primary Aldosteronism: How Often Are We Missing It?
Authors: Robert M. Centor, David A. Calhoun
Journal: Annals of Internal Medicine (2018)

Web Exclusives20 November 2018Annals On Call - Primary Aldosteronism: How Often Are We Missing It?FREERobert M. Centor, MD and David A. Calhoun, MDRobert M. Centor, MDHuntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Search for more papers by this author and David A. Calhoun, MDUniversity of Alabama Birmingham School of Medicine, Birmingham, Alabama (D.A.C.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/A18-0008 SectionsAboutVisual Abstract ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In this episode of Annals On Call, Dr. Centor discusses primary aldosteronism and hypertension with Dr. David Calhoun. Recent evidence suggest we may be missing the diagnosis more often than we think.Annals articles discussed include...The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study: http://annals.org/aim/article/doi/10.7326/M17-0882Subclinical Primary Aldosteronism: http://annals.org/aim/article/doi/10.7326/M17-2237About Annals On CallAnnals On Call focuses on a clinically influential article published in Annals of Internal Medicine. Dr. Robert Centor shares his own perspective on the material and interviews topic area experts to discuss, debate, and share diverse insights about patient care and health care delivery.For more information on Annals On Call and for more episodes, visit go.annals.org/OnCall. Comments0 CommentsSign In to Submit A Comment Author, Article, and Disclosure InformationAffiliations: Huntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)University of Alabama Birmingham School of Medicine, Birmingham, Alabama (D.A.C.)Disclosures: Dr. Centor has disclosed the following: Honoraria: Medscape. Dr. Calhoun has disclosed the following: Research Grants/Contracts: ReCor Medical.Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Proctor & Gamble, Pfizer, and Johnson & Johnson. Previousarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoThe Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension Jenifer M. Brown , Cassianne Robinson-Cohen , Miguel Angel Luque-Fernandez , Matthew A. Allison , Rene Baudrand , Joachim H. Ix , Bryan Kestenbaum , Ian H. de Boer , and Anand Vaidya Subclinical Primary Aldosteronism E. Victor Adlin Metrics Cited byThe Gout WarsBurton Abrams, MS 20 November 2018Volume 169, Issue 10Page: OC1KeywordsCohort studiesDiagnostic techniquesDisclosureHealth careHypertensionPatientsResearch grants ePublished: 20 November 2018 Issue Published: 20 November 2018 Copyright & PermissionsCopyright © 2018 by American College of Physicians. All Rights Reserved.Loading ...